CareDx, Inc (NASDAQ:CDNA) Q3 2023 Results Conference Call November 8, 2023 4:30 PM ET
Company Participants
Greg Chodaczek - Gilmartin Group, Managing Director
Alex Johnson - President of Patient and Testing Services
Abhishek Jain - Chief Financial Officer
Robert Woodward - Chief Scientific Officer
Michael Goldberg - Chairperson of the Board
Conference Call Participants
Andrew Cooper - Raymond James
Alex Nowak - Craig-Hallum Capital Group
Jacob Krahenbuhl - Stephens
Dipesh Patel - H.C. Weinright
Operator
Good day, everyone, and welcome to today's CareDx Inc. Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] Please note this call is being recorded. I’ll be standing by if you should need any assistance.
It is now my pleasure to turn the call over to Greg Chodaczek, Managing Director. Please go ahead.
Greg Chodaczek
Good afternoon and thank you for joining us today. Earlier today, CareDx released financial results for the quarter ended September 30, 2023. The release is currently available on the Company's website at www.caredx.com.
Joining the call today is Alex Johnson, President of CareDx's Patient and Testing Services; Abhishek Jain, Chief Financial Officer; and Robert Woodward, Chief Scientific Officer. Also joining on the call today is Michael Goldberg, Chairperson of the Board.
Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements within the meaning of the federal securities laws which are made pursuant to safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that are not statements of historical facts should be deemed to be forward-looking statements.
All forward-looking statements, including, without limitation, our examination of historical operating trends, expectations regarding coverage decisions, pricing and enrollment matters, and our financial expectations and results are based upon current estimates and various assumptions. These statements involve material risks and uncertainties that could cause actual results to differ materially from those anticipated or implied by these forward-looking statements.
Accordingly, you should not place undue reliance on these statements. For a list of descriptions of the risks and uncertainties associated with our business, please see our filings with the Securities and Exchange Commission. The information provided in this conference call speaks only to the live broadcast today, November 8, 2023. CareDx disclaims any intention or obligation, except required by law, to update or revise any information, financial projections or other forward-looking statements, whether because of new information, future events or otherwise.